Decision and Details
Not stated (absorption-type merger agreement executed on 13 November 2026)Absorption-type merger of Orchestra Holdings Co., Ltd. and Concerto Partners Co., Ltd.
This is an absorption-type merger between a wholly owned parent company and its wholly owned subsidiary, and the only shareholder of the absorbed company is the surviving company. Most of the absorbed company's liabilities are obligations to the surviving company, and an allowance for doubtful accounts equal to the amount of the excess liabilities has been recorded and will be reversed upon this absorption-type merger.
The surviving company is not expected to incur the loss prescribed in Article 795, Paragraph 2, Item 1 of the Companies Act as a result of this absorption-type merger. At present, no circumstances are anticipated that would impede the surviving company's performance of its obligations after the merger.
| Item | Details |
|---|---|
| Matter Covered | Absorption-type merger of Orchestra Holdings Co., Ltd. and Concerto Partners Co., Ltd. |
| Decision-Making Body | Not stated (absorption-type merger agreement executed on 13 November 2026) |
| Decision Date | 13 November 2026 (date of execution of the absorption-type merger agreement) |
| Implementation Date | 1 January 2027 (effective date, scheduled; subject to change if necessary for the merger process) |
| Period Covered | On or after 1 January 2027 (after the effective date) |
| Amount | Merger consideration: none; surviving company's stated capital and capital reserve: no change; Concerto Partners' borrowings: ¥94,000,000; total assets: ¥12,465,397; total liabilities: ¥107,023,388; total net assets: -¥94,557,991 |
| Quantity / scale | Issued shares of Concerto Partners: 1,500 shares (100% held by Orchestra Holdings) |
| Impact on Business Performance | The surviving company is not expected to incur the loss prescribed in Article 795, Paragraph 2, Item 1 of the Companies Act as a result of this absorption-type merger. At present, no circumstances are anticipated that would impede the surviving company's performance of its obligations after the merger. |
| Reason | This is an absorption-type merger between a wholly owned parent company and its wholly owned subsidiary, and the only shareholder of the absorbed company is the surviving company. Most of the absorbed company's liabilities are obligations to the surviving company, and an allowance for doubtful accounts equal to the amount of the excess liabilities has been recorded and will be reversed upon this absorption-type merger. |
| Governing Rule | Companies Act, Articles 782, Paragraph 1; 789; 784, Paragraph 1; 794, Paragraph 1; 795, Paragraph 2, Item 1; 796, Paragraph 2; and 799; and Ordinance for Enforcement of the Companies Act, Articles 182 and 191 |
| Related previous disclosures | The decision to conduct a share exchange with Sharing Innovations Co., Ltd. at a board meeting dated 25 August 2026 and execution of the share exchange agreement on the same date (no title stated) |
| Future plans | The absorption-type merger is scheduled to take effect on 1 January 2027. The two parties will carry out creditor protection procedures under Articles 789 and 799 of the Companies Act, including public notices and individual notices to known creditors. Any changes arising on or after the start date of the prior disclosure period will be disclosed without delay. |
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Orchestra Holdings holds all of the issued shares of Concerto Partners, so there is no risk of harming shareholders' interests even if no merger consideration is paid. Concerto Partners is, however, in a state of excess liabilities, most of which are liabilities to Orchestra Holdings. The companies expect no loss on the merger because the allowance for doubtful accounts will be reversed.